Last updated on February 2019

Non-interventional European Study of Trabectedin + PLD in the Treatment of Relapsed Ovarian Cancer (ROC) Patients

Brief description of study

Non-interventional, multicenter, prospective, European study to describe the effectiveness of trabectedin + PLD in the treatment of relapsed ovarian cancer (ROC) patients according to SmPC regardless of previous use of an antiangiogenic drug

Clinical Study Identifier: NCT02825420

Contact Investigators or Research Sites near you

Start Over

Evaristo Maiello, MD

IRCCS Casa Sollievo Della Sofferenza
San Giovanni Rotondo, Italy

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.